Indication
Obesity due to proopiomelanocortin (POMC) deficiency
Obesity due to proopiomelanocortin (POMC) deficiency is an extremely rare, autosomal recessive monogenic obesity disorder affecting the central nervous and endocrine systems. Read more about Obesity due to proopiomelanocortin (POMC) deficiency
1 drugs 1 manufacturers
Drugs that treat it
Common Obesity due to proopiomelanocortin (POMC) deficiency therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonObesity due to proopiomelanocortin (POMC) deficiency is an extremely rare, autosomal recessive monogenic obesity disorder affecting the central nervous and endocrine systems.
It is caused by homozygous or compound heterozygous loss-of-function variants in the *POMC* gene, which impairs the synthesis of key downstream cleavage peptides including alpha-melanocyte-stimulating hormone (a-MSH) and adrenocorticotropic hormone (ACTH).
Loss of a-MSH signaling at hypothalamic melanocortin-4 receptors (MC4R) disrupts central satiety and energy balance regulation, resulting in intractable, early-onset hyperphagia and severe pediatric obesity typically established within the first year of life.
Co-occurring features often include secondary adrenal insufficiency from ACTH deficiency—frequently presenting in infancy with hypoglycemia, seizures, or cholestasis—and hypopigmentation manifesting as pale skin and red hair due to absent melanocortin-1 receptor stimulation.
- orpha.net
Obesity due to proopiomelanocortin (POMC) deficiency is an extremely rare, autosomal recessive monogenic obesity disorder affecting the central nervous and endocrine systems It is caused by homozygous or compound heterozygous loss-of-function variants in the *POMC* gene, which impairs the synthesis of key downstream cleavage peptides including alpha-melanocyte-stimulating hormone (α-MSH) and adrenocorticotropic hormone (ACTH) Co-occurring features often include secondary adrenal insufficiency fr...
- rarediseases.org
Obesity due to proopiomelanocortin (POMC) deficiency is an extremely rare, autosomal recessive monogenic obesity disorder affecting the central nervous and endocrine systems
- obesitymedicinereview.com
It is caused by homozygous or compound heterozygous loss-of-function variants in the *POMC* gene, which impairs the synthesis of key downstream cleavage peptides including alpha-melanocyte-stimulating hormone (α-MSH) and adrenocorticotropic hormone (ACTH) Loss of α-MSH signaling at hypothalamic melanocortin-4 receptors (MC4R) disrupts central satiety and energy balance regulation, resulting in intractable, early-onset hyperphagia and severe pediatric obesity typically established within the firs...
- medlineplus.gov
Loss of α-MSH signaling at hypothalamic melanocortin-4 receptors (MC4R) disrupts central satiety and energy balance regulation, resulting in intractable, early-onset hyperphagia and severe pediatric obesity typically established within the first year of life
Personalize your experience
Follow Obesity due to proopiomelanocortin (POMC) deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.